Postprandial Carotenoid Response
Conditions
Keywords
Plasma carotenoid, Protein Type
Brief summary
The goal of this clinical trial is to learn if different protein types will affect carotenoid responses in humans when co-consumed with salad. The main questions it aims to answer are: * What are the effect of dietary protein co-consumption with salad on postprandial carotenoid levels in Singapore adults? * Do different whole-food protein sources enhance the bioavailability of carotenoids in Singapore adults? Participants will: Consume salad with a form of protein (chicken, tuna, egg, soybean) Have their postprandial plasma carotenoid and triglyceride outcomes evaluated
Detailed description
This study will be a single-blind, randomized, crossover acute trial, and all participants will complete an approximately 3-month study period. A total of 19 participants will be recruited and go through all 5 arms (4 intervention and 1 control), with the order randomized. The study will comprise 1 screening visit and 5 test visits, with another 5 compliance visits.
Interventions
OTHERSalad only
Control group, consumption of only salad
OTHERSalad + Chicken
Consumption of salad with chicken
OTHERSalad + Tuna
Consumption of salad with tuna
OTHERSalad + Egg
Consumption of salad with egg
OTHERSalad + Soybean
Consumption of salad with soybean
Sponsors
National University of Singapore
Study design
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
SINGLE (Investigator)
Eligibility
Sex/Gender
ALL
Age
21 Years to 45 Years
Healthy volunteers
Yes
Inclusion criteria
1. English-literate and able to give informed consent 2. Singaporean Adults aged 21 to 45 (inclusive) 3. Body mass index of 18.5 to 23.0 kg/m2 (inclusive) 4. At least 50 kg 5. Healthy (based on screening results)
Exclusion criteria
1. Currently participating in another clinical study that involves altering regular diet and/or involves consuming a dietary supplement or investigated food product as an intervention 2. High blood pressure (≥ 140/90 mmHg) 3. Underlying health conditions that may affect metabolic functions 4. Consuming carotenoid supplements regularly (i.e., more than three times a week) for the past 3 months, and not willing to discontinue consumption 3 months before and during the study duration 5. Weight change \> 3 kg in the past 3 months 6. Exercising vigorously over the past 3 months (i.e., engaging in high-intensity exercises for more than 3 hours a week, where high-intensity exercises leave one out of breath and unable to talk or sing during the workout) 7. Current smokers or have quit smoking for less than 5 years 8. Drinking \> 2 alcoholic drinks per day (i.e., one drink is defined as either 150 ml of wine, 340 ml of beer/cider or 45 ml of distilled spirit) 9. If drinking ≤ 2 alcoholic drinks per day, not willing to stop consumption of alcoholic beverages two days before and on the day of the test visits 10. Not willing to stop consumption of caffeinated beverages 10 to 12 hours before and on the day of the test visits 11. Currently on a specialised diet (e.g., vegetarian, vegan, weight loss diet) 12. Had serious food allergies in the past, or having intolerance, sensitivities or allergies to any of the following: soy/soy-derived products, eggs, fish and crustaceans, starch/starch-derived products (e.g., rice, corn, wheat, potato), gluten 13. Disease or impairment of the liver 14. Currently diagnosed with diabetes, gastrointestinal issues (e.g., lactose intolerance, irritable bowel syndrome), gout and/or G6PD deficiency 15. Taking antibiotics 2 weeks prior to study participation 16. Taking anti-hypertensive or cholesterol-lowering drugs for less than 3 years unless medically declared by an official doctor to be in stable condition 17. Poor peripheral venous access based on past experiences with blood drawing 18. Individuals with pacemaker or related electrical medical devices 19. Pregnant, lactating, or planning pregnancy in the next 6 months 20. Have donated blood (whole blood or apheresis) or participated in any other clinical study or trial requiring blood draws within the last 3 months 21. Clinical anemia (hemoglobin \<12.0 g/dL in women and \<13.0 g/dL in men)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Concentration of plasma carotenoids | From start of salad consumption to the end of acute period (8 hours) | Concentration of plasma carotenoids hourly |
| Concentration of blood triglycerides | From start of salad consumption to the end of acute period (8 hours) | Postprandial triglyceride response |
Countries
Singapore
Contacts
CONTACTWei Xi Khu, B.Sc.
PRINCIPAL_INVESTIGATORJung Eun Kim, Ph.D., R.D.
National University of Singapore, Department of Food Science and Technology
Outcome results
None listed